arXiv Machine Learning By Shan Yu, Xuening Wu

Auditable Algebraic Counting Field for Cryptic-Pocket Detection from Apo Structures

Read the original on arXiv Machine Learning →

The paper introduces a supervised algebraic counting field (ACF) that predicts cryptic ligand‑binding pocket residues from apo protein structures by compiling geometric, physicochemical, and topological features into compact integer‑weighted lookup tables. ACF allows each prediction score to be reconstructed from feature values, training counts, table weights, and spatial aggregation, eliminating the need for sequence search, structural‑template transfer, or a protein language model during inference. In benchmark tests on CryptoBench and external datasets, ACF outperformed the P2Rank method in mean paired ROC‑AUC on one external set, though gains varied across datasets and were not universally confirmed.

Machine-generated by The Flow from the publisher's headline and feed description — not written or checked by a human. The full article lives at arXiv Machine Learning.

arXiv AI
Sep 3

ProbeMatchDTI: Probe-Driven Multi-Scale Biochemical Pattern Matching for Drug-Target Interaction Prediction

ProbeMatchDTI is a new framework for drug‑target interaction prediction that uses probe‑driven pattern matching to preserve weak biochemical signals. It introduces IterProbe, which retains contextual states across refinement depths and selects them with learnable probes, and BindingProbe, which models drug‑protein complementarity at both local and whole‑pair levels. Experiments show that ProbeMatchDTI outperforms existing methods, improving AUC‑ROC by 2.0% on BindingDB and 0.5% on DrugBank, and its predictions can be integrated into downstream drug‑discovery workflows.

By Quan Hao, Mengyue Fan, Zifan Dong, Youru Li, Jianduo Zhao, Lechuan Xu, Hao Zhang, Fei Xia, Jigang Wang, Chong Qiu, Liguo Zhang
Hugging Face Trending Papers
Sep 2

ProbeMatchDTI: Probe-Driven Multi-Scale Biochemical Pattern Matching for Drug-Target Interaction Prediction

ProbeMatchDTI introduces a probe-driven framework for drug‑target interaction prediction that preserves weak biochemical signals by using IterProbe to retain contextual states and BindingProbe to model cross‑entity complementarity at multiple scales. The method improves AUC‑ROC by 2.0% on BindingDB and 0.5% on DrugBank compared to prior biochemical representation learning approaches. Feature‑level analyses confirm the effectiveness of the probe-driven pattern matching, and the predictions are linked to an evidence‑guided downstream drug‑discovery workflow for candidate refinement and validation planning.

arXiv Machine Learning
Aug 28

Interpreting Latent Protein Language Model Features with Geometric Annotations

The paper introduces a scalable method to interpret sparse autoencoder (SAE) features in the ESM-2 protein language model by leveraging geometrically inspired features of the protein α‑carbon backbone. Across 8M layers of ESM-2, a false discovery rate–controlled analysis shows that local geometry is significantly associated with many SAE features, revealing substructure within known biological labels and enabling annotation of unannotated metagenomic proteins. Ablation experiments demonstrate that removing these geometric features shifts ESM-2’s predicted contact maps toward the descriptor, linking mechanistic interpretability with structural biology.

By Siddharth Setlur, Djordje Mihajlovic, Darrick Lee
arXiv Machine Learning
2d ago

Designing Protein Structures from Natural Language

The paper introduces Prompteina, an all‑atom protein structure generation model that accepts natural‑language descriptions of desired structural and functional properties, similar to text‑to‑image systems. It is trained on a large paired dataset of 1.8 million protein structures and over 50 million captions, and fine‑tuned from the Proteina‑Complexa model to align residues with textual cues. Prompteina outperforms existing baselines on most structural metrics, improves binder design performance, and experimentally validates nine new binders for the GM2A target.

By Joseph Lee, Yanjing Li, Bo Qiang, Gregory Lau, Allyson Ettinger, Noah A. Smith, Rory Donovan-Maiye, David Baker, Hanna Hajishirzi, Pang Wei Koh